Staff Profile

I am a Consultant Allied Health Professional (AHP)/Clinical Academic Physiotherapist and NIHR Senior Clinical and Practitioner Research Awardee (SCPRA) within the Liver Unit at the Newcastle upon Tyne Hospitals NHS Foundation Trust (NuTH), UK. I completed my PhD at Newcastle University on ‘Physical activity and exercise in MASLD’ and have published world-leading research in the field of lifestyle management for patients with long-term conditions. More recently, my research has looked at why lifestyle interventions are not being optimised in clinical practice and what tools are necessary to aid healthcare professionals to support patients to make lifestyle changes. I led the development of an evidence-based MASLD-specific digital intervention which was co-designed with patients and has been piloted within the NHS in Newcastle.

Clinically, I led the development and implementation of an innovative AHP-led structured group education programme for patients with MASLD within one of the largest MASLD services in the UK. I co-led an Active Hospitals Pilot which aimed to embed physical activity in care pathways across NuTH and am leading work to support patients with long-term conditions to self-manage their health using non-pharmacological interventions.

I am part of the European Association for the Study of the Liver (EASL) Nurse and AHP Taskforce and the British Association for the Study of the Liver (BASL) AHP Committee. I was part of international groups writing EASL MASLD Patient Guidelines, and position statements from the American College of Sports Medicine (ACSM) and Exercise and Sports Science Australia (ESSA) on physical activity and exercise in MASLD. In 2021, I was awarded the prestigious EASL Rising Star Award for my work which focuses on putting people with, or at risk of, liver disease at the heart of my practice.

Qualifications

• PhD - Newcastle University (UK)
• BSc (Hons) Physiotherapy - Northumbria University (UK)
• ACSM Certified Clinical Exercise Specialist

Memberships

• Chartered Society of Physiotherapy
• Health Professions Council
• European Association for the Study of the Liver
• British Association for the Study of the Liver

Honours and Awards

• NIHR/HEE CAT Clinical Lecturship 2015-2020
• NIHR DSE Award 2020-2022
• NHSE/HEE Population Health Management Fellowship 2023-2024
• NIHR SCPRA Fellowship 2024-2029
• EASL Rising Star Award 2021
• NuTH Celebrating Excellence Award 2024 for the Active Hospitals Pilot

Informal Interests

Running, skiing/snowboarding, netball... playing/watching any sport! 

My research focuses on the use of non-pharmacological interventions in the management of long-term conditions.

I am currently an NIHR SCPRA Fellow and the NIHR Newcastle BRC PPIE Lead for the 'Liver, lifestyle and mulitmorbidity' theme.

• Articles

  • Crame T, Howarth R, Johnstone E, Smith H, McPherson S, Hallsworth K. Prospective evaluation of a structured group education programme for patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Frontline Gastroenterology 2025, epub ahead of print.
  • Stefanetti RJ, Charman SJ, Newman J, Hallsworth K, Blain AP, Ng YS, Gorman GS. Outcomes misaligned in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): implications for trial design. Brain Communications 2025, 7(5), fcaf342.
  • Avery L, Smith H, Livingston R, McPherson S, Innerd A, Hallsworth K. Feasibility of a digital lifestyle intervention (VITALISE) to support weight loss in patients with MASLD in routine secondary care. BMJ Open Gastroenterology 2025, 12, e001771.
  • Smith H, Livingston R, Ashley K, Cooper M, McPherson S, Innerd A, Hallsworth K, Avery L. Effectiveness and active ingredients of digital behaviour change interventions for MASLD: A systematic review and meta-analysis. JHEP Reports 2025, 7(10), 101507.
  • Orange ST, Brown MC, Hallsworth K, Malcomson FC, Corfe B, Tweedie C, Cresti N, Cain H, Court P, Willson C, Ross K, Mathers JC, Saxton JM, Sharp L, Smith SG. Co-development of a programme to improve physical activity support for women after breast cancer treatment: a pre-protocol for PURE-EX [version 1; peer review: awaiting peer review] . NIHR Open Research 2025, 5(3).
  • Charman SJ, Blain AP, Okwose NC, Fuller AS, Alyahya AI, Hallsworth K, Eggett C, Luke P, Bailey K, MacGowan GA, Jakovljevic DG. Physical Activity, Inactivity and Sleep in Individuals with Hypertrophic Cardiomyopathy. International Journal of Sports Medicine 2024, 45(02), 149-154.
  • Hallsworth K, McCain MV, Fallen-Bailey R, Brown MC, Orange ST, Reeves HL. Is home-based, virtually-delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer). BMJ Open 2024, 14(6), e082155.
  • Fong M, Kaner E, Rowland M, Graham HE, McEvoy L, Hallsworth K, Cucato G, Gibney C, Nedkova M, Prentis J, Madigan CD. The effect of preoperative behaviour change interventions on pre- and post-surgery health behaviours, health outcomes, and health inequalities in adults: A systematic review and meta-analyses. PLoS ONE 2023, 18(7), e0286757.
  • McPherson S, Jarvis H, McGonigle J, Bedlington J, Dean J, Hallsworth K, Hanon E, Liddle T, Luvai A, Mansour D, Patel P, Renwick L, Teare D, Tanney C, Anstee Q. Stratification of LIver Disease (SOLID): Protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary-secondary care interface. BMJ Open Gastroenterology 2023, 10(1), e001092.
  • Karsdal MA, Hallsworth K, Scragg J, Leeming DJ, Villesen IF, Avery L, Haigh L, Govaere O, Wichmann S, Taylor G, Cassidy S, McPherson S, Anstee QM. Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease. Hepatology Communications 2023, 7(10), e0254.
  • Parker R, Allison M, Anderson S, Aspinall R, Bardell S, Bains V, Buchanan R, Corless L, Davidson I, Dundas P, Fernandez J, Forrest E, Forster E, Freshwater D, Gailer R, Goldin R, Hebditch V, Hood S, Jones A, Lavers V, Lindsay D, Maurice J, McDonagh J, Morgan S, Nurun T, Oldroyd C, Oxley E, Pannifex S, Parsons G, Phillips T, Rainford N, Rajoriya N, Richardson P, Ryan J, Sayer J, Smith M, Srivastava A, Stennett E, Towey J, Vaziri R, Webzell I, Wellstead A, Dhanda A, Masson S. Quality standards for the management of alcohol-related liver disease: Consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group. BMJ Open Gastroenterology 2023, 10(1), e001221.
  • Avery L, Smith H, McPherson S, Hallsworth K. Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE). Pilot and Feasibility Studies 2023, 9, 62.
  • Orange ST, Hallsworth K, Brown MC, Reeves HL. The feasibility and acceptability of a home-based, virtual exercise intervention for older patients with hepatocellular carcinoma: protocol for a non-randomised feasibility study (TELEX-Liver Cancer). Pilot And Feasibility Studies 2022, 8, 113.
  • Anstee QM, Hallsworth K, Lynch N, Hauvespre A, Mansour E, Kozma S, Marino J-P, Bottomley J, Piercy J, Higgins V. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Reports 2022, 4(1), 100411.
  • McPherson S, Armstrong MJ, Cobbold JF, Corless L, Anstee QM, Aspinall RJ, Barclay ST, Brennan PN, Cacciottolo TM, Goldin RD, Hallsworth K, Hebditch V, Jack K, Jarvis H, Johnson J, Li W, Mansour D, McCallum M, Mukhopadhya A, Parker R, Ross V, Rowe IA, Srivastava A, Thiagarajan P, Thompson AI, Tomlinson J, Tsochatzis EA, Yeoman A, Alazawi W. Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group. Lancet Gastroenterology and Hepatology 2022, 7(8), 755-769.
  • Cooper M, Chmelo J, Sinclair RCF, Charman S, Hallsworth K, Welford J, Phillips AW, Greystoke A, Avery L. Exploring factors influencing uptake and adherence to a home-based prehabilitation physical activity and exercise intervention for patients undergoing chemotherapy before major surgery (ChemoFit): a qualitative study. BMJ Open 2022, 12(9), e062526.
  • Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Cooper M, Sinclair RCF. A feasibility trial of prehabilitation before oesophagogastric cancer surgery using a multi-component home-based exercise programme: the ChemoFit study. Pilot and Feasibility Studies 2022, 8(1), 173.
  • Neilson LJ, MacDougall L, Lee PS, Hardy T, Beaton D, Chandrapalan S, Ebraheem A, Hussien M, Galbraith S, Looi S, Oxenburgh S, Phaw NA, Taylor W, Haigh L, Hallsworth K, Mansour D, Dyson JK, Masson S, Anstee Q, McPherson S. Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease. Frontline Gastroenterology 2021, 12(7), 578-585.
  • Scragg J, Hallsworth K, Taylor G, Cassidy S, Haigh L, Boyle M, Anstee QM, McPherson S, Avery L. Factors associated with engagement and adherence to a low energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease. BMJ Open Gastroenterology 2021, 8(1), e000678.
  • Hallsworth K, McPherson S, Anstee QM, Flynn D, Haigh L, Avery L. Digital Intervention with Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults with Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping. Journal of Medical Internet Research 2021, 23(1), e20491.
  • Hallsworth K, Gosrani S, Hogg S, Patel P, Wetten A, Welton R, McPherson S, Campbell M. Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis C. BMJ Open Gastroenterology 2021, 8(1), e000591.
  • McPherson S, Gosrani S, Hogg S, Patel P, Wetten A, Welton R, Hallsworth K, Campbell M. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C. BMJ Open Gastroenterology 2020, 7(1), e000470.
  • Scragg J, Avery L, Cassidy S, Taylor G, Haigh L, Boyle M, Trenell MI, Anstee QM, McPherson S, Hallsworth K. Feasibility of a very low calorie diet to achieve a sustainable 10% weight loss in patients with non-alcoholic fatty liver disease. Clinical and Translational Gastroenterology 2020, 11(9), e00231.
  • Chmelo J, Phillips AW, Greystoke A, Charman SJ, Avery L, Hallsworth K, Welford J, Sinclair RCF. A feasibility study to investigate the utility of a home-based exercise intervention during and after neo-adjuvant chemotherapy for oesophago-gastric cancer-the ChemoFit study protocol. Pilot and Feasibility Studies 2020, 6(1), 50.
  • Hallsworth K, Dombrowski SU, McPherson S, Anstee QM, Avery L. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. Translational Behavioural Medicine 2019, (ePub ahead of Print).
  • Houghton D, Zalewski P, Hallsworth K, Cassidy S, Thoma C, Avery L, Slomko J, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Newton JL, Trenell MI. The degree of hepatic steatosis associates with impaired cardiac and autonomic function. Journal of Hepatology 2019, 70(6), 1203-1213.
  • Hallsworth K, Adams LA. Lifestyle modification in NAFLD/NASH: Facts and figures. JHEP Reports 2019, 1(6), 468-479.
  • Haigh L, Bremner S, Houghton D, Henderson E, Avery L, Hardy T, Hallsworth K, McPherson S, Anstee QM. Barriers and Facilitators to Mediterranean Diet Adoption by Patients with Non-alcoholic Fatty Liver Disease in Northern Europe. Clinical Gastroenterology and Hepatology 2019, 17(7), 1364-1371.e3.
  • Cassidy S, Okwose N, Scragg J, Houghton D, Ashley K, Trenell MI, Jakovljevic DG, Hallsworth K, Avery L. Assessing the feasibility and acceptability of Changing Health for the management of prediabetes: protocol for a pilot study of a digital behavioural intervention. Pilot and Feasibility Studies 2019, 5, 139.
  • Cassidy S, Vaidya V, Houghton D, Zalewski P, Seferovic JP, Hallsworth K, MacGowan GA, Trenell MI, Jakovljevic DG. Unsupervised high-intensity interval training improves glycaemic control but not cardiovascular autonomic function in type 2 diabetes patients: A randomised controlled trial. Diabetes and Vascular Disease Research 2018, 16(1), 69-76.
  • Shaw A, Houghton D, Hallsworth K, Jakovljevic DG, Trenell MI, Cassidy S. Adiposity predicts low cardiorespiratory fitness in individuals with metabolic diseases. Diabetes Research and Clinical Practice 2018, 146, 300-304.
  • Avery L, Exley C, McPherson S, Trenell MI, Anstee QM, Hallsworth K. Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice. Clinical Gastroenterology and Hepatology 2017, 15(12), 1968-1971.
  • Houghton D, Thoma C, Hallsworth K, Cassidy S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day CP, McPherson S, Anstee QM, Trenell MI. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 2017, 15(1), 96-102.e3.
  • Houghton D, Hallsworth K, Thoma C, Cassidy S, Hardy T, Heaps S, Hollingsworth KG, Taylor R, Day CP, Masson S, McPherson S, Anstee QM, Trenell MI. Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. Clinical Gastroenterology and Hepatology 2017, 15(10), 1596-1603.e3.
  • Ramdharry GM, Pollard AJ, Grant R, Dewar EL, Laura M, Moore SA, Hallsworth K, Ploetz T, Trenell MI, Reilly MM. A study of physical activity comparing people with Charcot-Marie-Tooth disease to normal control subjects. Disability and Rehabilitation 2017, 39(17), 1753-1758.
  • Hallsworth K, Avery L, Trenell MI. Targeting lifestyle behaviour change in adults with NAFLD during a 20 minute consultation: Summary of the dietary and exercise literature. Current Gastroenterology Reports 2016, 18(3), 1-7.
  • Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Taylor R, Jakovljevic DG, Trenell MI. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2016, 59(1), 56-66.
  • Hallsworth K, Jopson L, Jones DE, Trenell MI. Exercise therapy in Primary Biliary Cirrhosis: The importance of moving whilst sitting on a surgical waiting list - a case study. Frontline Gastroenterology 2016, 7(3), 167-169.
  • Hallsworth K, Thoma C, Hollingsworth KG, Cassidy S, Anstee QM, Day CP, Trenell MI. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: A randomised controlled trial. Clinical Science 2015, 129(12), 1097-1105.
  • Moore SA, Hallsworth K, Jakovljevic DG, Blamire AM, He JB, Ford GA, Rochester L, Trenell MI. Effects of Community Exercise Therapy on Metabolic, Brain, Physical, and Cognitive Function Following Stroke: A Randomized Controlled Pilot Trial. Neurorehabilitation & Neural Repair 2015, 29(7), 623-635.
  • Cassidy S, Hallsworth K, Thoma C, MacGowan GA, Hollingsworth KG, Day CP, Taylor R, Jakovljevic DG, Trenell MI. Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control. Cardiovascular Diabetology 2015, 14, 23.
  • Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, Day CP, Trenell MI. Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterology 2014, 1-8.
  • Jakovljevic DG, McDiarmid A, Hallsworth K, Seferovic PM, Ninkovic VM, Parry G, Schueler S, Trenell MI, MacGowan GA. Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life. American Journal of Cardiology 2014, 114(1), 88-93.
  • Jakovljevic DG, Hallsworth K, Zalewski P, Thoma C, Klawe J, Day CP, Newton J, Trenell MI. Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease. Clinical Science 2013, 125(3), 143-149.
  • Moore SA, Hallsworth K, Plötz T, Ford GA, Rochester L, Trenell MI. Physical activity, sedentary behaviour and metabolic control following stroke: A cross-sectional and longitudinal study. PLoS One 2013, 8(1), e55263.
  • Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic DG, MacGowan GA, Anstee QM, Taylor R, Day CP, Trenell MI. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. Journal of Hepatology 2013, 58(4), 757-762.
  • Moore SA, Hallsworth K, Bluck LJC, Ford GA, Rochester L, Trenell MI. Measuring Energy Expenditure After Stroke Validation of a Portable Device. Stroke 2012, 43(6), 1660-1662.
  • Jakovljevic DG, Moore S, Hallsworth K, Fattakhova G, Thoma C, Trenell MI. Comparison of cardiac output determined by bioimpedance and bioreactance methods at rest and during exercise. Journal of Clinical Monitoring and Computing 2012, 26(2), 63-68.
  • Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011, 60(9), 1278-1283.
  • Newton JL, Pairman J, Hallsworth K, Moore S, Ploetz T, Trenell MI. Physical activity intensity but not sedentary activity is reduced in chronic fatigue syndrome and is associated with autonomic regulation. QJM 2011, 104(8), 681-687.

• Conference Proceedings (inc. Abstracts)

  • Hallsworth K, Orange ST, McCain M, Fallen-bailey R, Reeves HL. Feasibility of a home-based, virtually-delivered, group exercise intervention in older patients with liver cancer (TELEX-Liver Cancer). In: EASL Congress 2023. 2023, Vienna, Austria: Elsevier BV.
  • Houghton D, Zalewski P, Cassidy S, Thoma C, Hallsworth K, Avery L, Lukowska AB, Hardy T, Burt AD, Masson S, Day C, McPherson S, Anstee QM, Newton JL, Trenell MI. Autonomic function is impaired across the spectrum of NAFLD. In: The International Liver Congress 2017: 52nd Annual Meeting of the European Association for the Study of the Liver. 2017, Amsterdam, The Netherlands: Elsevier BV.
  • Houghton DH, Thoma CT, Cassidy SC, Hallsworth KH, Hollingsworth KGH, Taylor RT, Day CPD, Anstee QMA, Trenell MIT. Exercise reduces liver fat and improves body composition but not insulin sensitivity or inflammatory markers in non-alcoholic steatohepatitis. In: Diabetes UK Professional Conference. 2016, Glasgow: Wiley-Blackwell Publishing Ltd.
  • Moore S, Hallsworth K, Ploetz T, Ford GA, Rochester L, Trenell MI. Physical activity, sedentary behavior and metabolic control following stroke: A cross-sectional and longitudinal study. In: The European Stroke Organisation Annual Conference. 2015, Glasgow, UK: Wiley-Blackwell Publishing Ltd.
  • Cassidy S, Thoma C, Hallsworth K, Parikh J, Hollingsworth KG, Day CP, Jakovljevic DG, Taylor R, Trenell MI. High intensity intermittent training improves cardiac function and reduces liver fat in adults with Type 2 diabetes: an MRI/S study. In: Diabetes UK Professional Conference. 2015, London, UK: Wiley-Blackwell Publishing Ltd.
  • Houghton D, Thoma C, Hallsworth K, Hollingsworth KG, Day CP, Anstee QM, Trenell MI. Exercise reduces liver fat, visceral fat and circulating triglycerides, but not circulating inflammatory markers in non-alcoholic steatohepatitis. In: The International Liver Congress 2015 - 50th Annual meeting of the European Association for the Study of the Liver. 2015, Vienna, Austria: Elsevier BV.
  • Cassidy SA, Thoma C, Hallsworth K, Jakovljevic DG, Parikh J, Hollingsworth KG, Taylor R, Trenell MI. High intensity intermittent exercise reverses abnormal cardiac function in people with type 2 diabetes: an MRI/S study. In: 50th General Assembly of the European Association for the Study of Diabetes. 2014, Vienna, Austria: Springer.
  • Moore S, Hallsworth K, Jakovljevic D, Blamire A, He J, Ford G, Rochester L, Trenell M. Effects of exercise therapy on metabolic risk factors, brain atrophy and cerebral blood flow following stroke: A randomised controlled trial. In: UK Stroke Forum 2014. 2014, Harrogate: Wiley-Blackwell Publishing Asia.
  • Cassidy SA, Hallsworth K, Thoma C, Hollingsworth K, Jakovljevic J, Trenell MI. Cardiac structure and function is altered in adults with metabolic disorders. In: Diabetes UK Professional Conference 2014. 2014, Liverpool, UK: Wiley-Blackwell.
  • Thoma C, Hallsworth K, Hollingsworth K, Taylor R, Day CP, Trenell M. Unsupervised high-intensity intermittent training reduces liver fat and improves body composition in adults with non-alcoholic fatty liver disease (NAFLD). In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell.
  • Thoma C, Hallsworth K, Hollingsworth K, Anstee Q, Taylor R, Day C, Trenell M. HIGH-INTENSITY INTERMITTENT EXERCISE THERAPY REDUCES LIVER FAT AND IMPROVES BODY COMPOSITION IN ADULTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. In: 48th Annual Meeting of the European Association for the Study of the Liver. 2013, Amsterdam, The Netherlands: Elsevier BV.
  • Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Day CP, Trenell MI. Higher Objectively Measured Sedentary Behaviour and Lower Levels of Physical Activity than Matched Healthy Controls. In: 48th Annual meeting of the European Association for the Study of the Liver. 2013, Amsterdam, Netherlands: Elsevier BV.
  • Hallsworth K, Hollingsworth KG, Thoma C, Anstee QM, Day CP, Trenell MI. Cardiac Function Improves Following High Intensity Intermittent Exercise Therapy in Non-Alcoholic Fatty Liver Disease. In: 48th Annual meeting of the European Association for the Study of the Liver. 2013, Amsterdam, Netherlands: Elsevier Science BV.
  • Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic DG, MacGowan GA, Anstee QM, Day CP, Taylor R, Trenell MI. Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease. In: Diabetes UK Annual Professional Conference. 2013, Manchester, UK: Diabetes UK.
  • Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, Day CP, Taylor R, Trenell MI. Cardiac function improves following high intensity intermittent exercise in adults with non-alcoholic fatty liver disease. In: Diabetes UK Professional Conference 2013. 2013, Manchester, UK: Wiley-Blackwell.
  • Hallsworth K, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Physical activity levels are lower in people with non-alcoholic fatty liver disease than matched healthy controls. In: Diabetes UK Annual Professional Conference. 2012, Glasgow, UK.
  • Hallsworth K, Hollingsworth KG, Thoma C, Taylor R, Day CP, Trenell MI. Cardiac structure and function is altered in adults with non-alcoholic fatty liver disease. In: EuroPRevent: The European Society of Cardiology Congress. 2012, Dublin, Ireland.
  • Hallsworth K, Hollingsworth KG, Thoma C, Taylor R, Day CP, Trenell MI. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. In: 47th Annual Meeting of the European Association for the Study of the Liver (EASL). 2012, Barcelona, Spain: Elsevier BV.
  • Hallsworth K, Fattakhova G, Hollingsworth K, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise improves liver lipid, fat oxidation and glucose control in adults with non-alchoholic fatty liver disease independent of weight loss. In: Journal of Hepatology: 46th Annual Meeting of the European Association for the Study of the Liver (EASL). 2011, Berlin, Germany: Elsevier BV.
  • Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Day CP, Taylor R, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD). 2011, Lisbon, Portugal: EASD.
  • Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: Chartered Society of Physiotherapy Annual Congress. 2011, Liverpool, UK.
  • Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, Day CP, Trenell MI. Resistance exercise improves liver fat and glucose control in people with non-alcoholic fatty liver disease. In: Diabetes UK Annual Professional Conference. 2011, London, UK.
  • Pollard A, Ramdharry GM, Moore S, Hallsworth K, Marsden JF, Reilly MM. Comparing activity levels between people with Charcot-Marie-Tooth disease and healthy controls - a pilot study. In: United Kingdom Neuromuscular Translational Research Conference. 2010, Oxford: Neuromuscular Disorders, Elsevier.

• Letter

  • Scragg J, Charman SJ, van Hees VT, Avery L, Taylor GS, Anstee QM, McPherson S, Cassidy S, Hallsworth K. Physical Activity, Inactivity and Sleep in Patients with Significant Non-Alcoholic Fatty Liver Disease. American Journal of the Medical Sciences 2022, 363(1), 80-83.

• Review

  • Keating SE, Sabag A, Hallsworth K, Hickman IJ, Macdonald GA, Stine JG, George J, Johnson NA. Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia. Sports Medicine 2023, 53, 2347-2371.